Goldman Sachs’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.41M	Buy	151,857 +26,162	+21%	+$243K	﹤0.01%	3631
2025 Q1	$1.64M	Sell	125,695 -54,054	-30%	-$704K	﹤0.01%	3498
2024 Q4	$3.13M	Buy	179,749 +77,854	+76%	+$1.36M	﹤0.01%	3199
2024 Q3	$2.6M	Buy	+101,895	New	+$2.6M	﹤0.01%	3183